13 results
424B4
NRBO
NeuroBo Pharmaceuticals Inc
7 Nov 22
Prospectus supplement with pricing info
9:07am
in an intravenous formulation. Molnupiravir is not recommended in children ≤18 years as well as pregnant women and those trying to become pregnant. Nirmatrelvir
424B5
gru2uyg90l3
15 Apr 20
Prospectus supplement for primary offering
5:19pm
8-K
EX-99.1
fuuur3oxg 3ljtyq
24 Sep 19
Other Events
4:17pm
425
EX-99.1
mn6hzltjbp4xmd
24 Sep 19
Business combination disclosure
4:15pm
8-K
EX-99.2
kvdx4b52br jz01h
28 Jun 18
ADVANCING CARDIOVASCULAR AND NASH OPPORTUNITIES INDIGO-1 Trial Top-Line Results June 28th, 2018
4:30pm
424B3
yqzvm3a2 n6aa99
21 Apr 17
Prospectus supplement
12:00am
10-K
lk0sr xus32dndunpc
21 Mar 17
Annual report
12:00am
- Prev
- 1
- Next